antivirus program

(redirected from antiviral program)

antivirus program

[‚an·tē′vī·rəs ‚prō·grəm] antivirus software
McGraw-Hill Dictionary of Scientific & Technical Terms, 6E, Copyright © 2003 by The McGraw-Hill Companies, Inc.

antivirus program

This article is provided by FOLDOC - Free Online Dictionary of Computing (foldoc.org)

antivirus program

Software that searches for viruses. Also known as a "virus scanner." As new viruses are discovered by the antivirus vendor, their binary patterns and behaviors are added to a database that is downloaded periodically to the user's antivirus program via the Web. Popular antivirus programs are Norton, McAfee, Sophos, Bitdefender, AVG and Kaspersky. Windows Defender is Microsoft's own antivirus software that comes with Windows, starting with Windows 8.

Antivirus programs are used on all Windows machines, but most Mac users do not install them. However, as more Macs are acquired, the Mac has slowly but surely become a target of attacks, and Mac antivirus programs are being installed at a more rapid rate than in the past. See virus, quarantine, disinfect and scareware.

Multiple Detection Approaches
Early antivirus scanning matched the binary signature (pattern) of executable files against a database of known malware signatures before they were allowed to run. This "scanning" process was vastly speeded up by doing a one-time scan of all the executables in the computer and also when a new one is installed. If the executable is virus free, a checksum (hash) of its binary pattern is computed and stored in a checksum database. The next time the executable is launched by the user, its checksum is recomputed and compared with the virus-free checksum. If they match, the file was not adulterated.

Because malware may generate a unique signature each time it is downloaded to an unsuspecting user, antivirus programs also use behavior detection, which looks for suspicious activities such as copying and deleting files when launched (see behavior detection). See Symantec, McAfee, Sophos, Bitdefender, AVG, checksum, virus, polymorphic virus and Reputation-based Security.


Scan and Create a Checksum (Hash)
This is commonly used to speed up antivirus scanning, because computing and comparing an executable's checksum is considerably faster than analyzing the file each time it is loaded.
Copyright © 1981-2019 by The Computer Language Company Inc. All Rights reserved. THIS DEFINITION IS FOR PERSONAL USE ONLY. All other reproduction is strictly prohibited without permission from the publisher.
References in periodicals archive ?
ENPNewswire-August 22, 2019--CIDARA THERAPEUTICS TO PRESENT DATA FROM ITS CLOUDBREAK ANTIVIRAL PROGRAM AT THE OPTIONS X FOR THE CONTROL OF INFLUENZA CONFERENCE
M2 PHARMA-August 22, 2019-Cidara Therapeutics to Present Data from its Cloudbreak Antiviral Program at the Options X for the Control of Influenza Conference
In addition to targeting specific genes in the body, AVI's antiviral program uses NeuGene antisense compounds to combat disease by targeting single-stranded RNA viruses, including West Nile virus, hepatitis C virus, dengue virus, Ebola virus, and H5N1 avian influenza virus.
The techniques used in an antiviral program vary from product to product.
In addition to targeting specific genes in the body, AVI's antiviral program uses NEUGENE antisense compounds to combat disease by targeting single-stranded RNA viruses, including hepatitis C virus, influenza A virus, West Nile virus, dengue virus and Ebola virus.
(NASDAQ: GILD) announced today that it has licensed three preclinical antiviral programs from Novartis, including investigational agents with the potential to treat human rhinovirus, influenza and herpes viruses.
Because programs and operating systems are not usually designed with security in mind, antiviral programs will always be behind the curve, says Jajodia.
In addition to routine security procedures, special antiviral programs can help combat the virus threat.
'We see opportunity for us to successfully leverage the potential depth, breadth and efficacy of our antiviral programs within the current environment of significant deal activity between leading biopharmaceutical/ pharma companies and biotech companies.
(NASDAQ: GILD) has licensed three preclinical antiviral programs from Swiss drugmaker Novartis, including investigational agents with the potential to treat human rhinovirus, influenza and herpes viruses, the company said.